Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center

Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center

Advanced therapy medical products (ATMPs) are rapidly growing as innovative medicines for the treatment of several diseases. Hence, the role of quality analytical tests to ensure consistent product safety and quality has become highly relevant. Several clinical trials involving dendritic cell (DC)-b...

Full description

Bibliographic Details
Main Authors: Elena Pancisi, Anna Maria Granato, Emanuela Scarpi, Laura Ridolfi, Silvia Carloni, Cinzia Moretti, Massimo Guidoboni, Francesco De Rosa, Sara Pignatta, Claudia Piccinini, Valentina Soldati, Luana Calabrò, Massimo Framarini, Monica Stefanelli, Jenny Bulgarelli, Marcella Tazzari, Francesca Fanini, Massimiliano Petrini
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Vaccines
Subjects:
immunotherapy
dendritic cell vaccine
quality control
ATMP
stability
Online Access:https://www.mdpi.com/2076-393X/10/7/999

Internet

https://www.mdpi.com/2076-393X/10/7/999

Similar Items